Medifocus Inc (MFS):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Medifocus Inc (MFS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9446
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Medifocus Inc (Medifocus) is a medical technology company. The company develops and commercializes minimally invasive focused heat systems for the treatment of cancerous and benign tumors, and enlarged prostate. Its technology platforms includes endo-thermotherapy platform, a catheter-based focused heat technology platform that utilizes natural body openings to deliver microwave thermotherapy to the diseased sites; and adaptive phased array (APA) microwave focusing platform, which directs microwave energy at tumor center to induce shrinkage and eradication of tumors without undue harm to surrounding tissue. The company develops heat-activated and tumor-targeted immunotherapy and gene therapy technology for the treatment of cancers and other diseases; and APA 1000, a minimally invasive breast cancer treatment system, which is in pivotal Phase-III clinical trials. It has operations in Canada and the US. Medifocus is headquartered in Toronto, Ontario, Canada.

Medifocus Inc (MFS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Medifocus Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Medifocus Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Medifocus Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Medifocus Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Medifocus Inc, Medical Devices Deals, 2012 to YTD 2018 9
Medifocus Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Medifocus Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Medifocus Enters into R&D and Manufacturing Agreement with Yuanxing Bio-Pharm 11
Medifocus To Form Joint Venture With Ideal Concept 12
Licensing Agreements 13
Medifocus Enters into Licensing Agreement with Duke University 13
Equity Offering 14
Medifocus Raises USD1.8 Million in Private Placement of Shares 14
Medifocus Raises USD1.6 Million in Private Placement of Units 15
Medifocus Completes Second Tranche Of Private Placement Of Units For US$5.3 Million 16
Medifocus Completes Private Placement Of Units For US$2 Million 18
Medifocus Inc – Key Competitors 19
Medifocus Inc – Key Employees 20
Medifocus Inc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Financial Announcements 22
Aug 28, 2017: Medifocus Announces Significant Improvement in Operating Results for the Fiscal Year Ending March 31, 2017 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Medifocus Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Medifocus Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Medifocus Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Medifocus Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Medifocus Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Medifocus Inc, Medical Devices Deals, 2012 to YTD 2018 9
Medifocus Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Medifocus Enters into R&D and Manufacturing Agreement with Yuanxing Bio-Pharm 11
Medifocus To Form Joint Venture With Ideal Concept 12
Medifocus Enters into Licensing Agreement with Duke University 13
Medifocus Raises USD1.8 Million in Private Placement of Shares 14
Medifocus Raises USD1.6 Million in Private Placement of Units 15
Medifocus Completes Second Tranche Of Private Placement Of Units For US$5.3 Million 16
Medifocus Completes Private Placement Of Units For US$2 Million 18
Medifocus Inc, Key Competitors 19
Medifocus Inc, Key Employees 20
Medifocus Inc, Other Locations 21

List of Figures
Medifocus Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Medifocus Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Medifocus Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Medifocus Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Medifocus Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Medifocus Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Medifocus Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Medifocus Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Medifocus Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Medifocus Inc (MFS):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Smiths Detection Group Limited:戦略・SWOT・企業財務分析
    Smiths Detection Group Limited - Strategy, SWOT and Corporate Finance Report Summary Smiths Detection Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • VT Holdings Co Ltd (7593):企業の財務・戦略的SWOT分析
    VT Holdings Co Ltd (7593) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Bashneft (BANE):企業の財務・戦略的SWOT分析
    Bashneft (BANE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Superior Energy Services, Inc.:企業の戦略・SWOT・財務情報
    Superior Energy Services, Inc. - Strategy, SWOT and Corporate Finance Report Summary Superior Energy Services, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Gilead Sciences Inc (GILD)-医療機器分野:企業M&A・提携分析
    Summary Gilead Sciences Inc (Gilead) is a research-based biopharmaceutical company. It focuses on the discovery, development and commercialization of medicines for the treatment of cardiovascular and respiratory diseases, inflammation, liver diseases, cancer and human immunodeficiency virus (HIV) in …
  • 3W Power S.A. (3W9K):企業の財務・戦略的SWOT分析
    3W Power S.A. (3W9K) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Benefitfocus Inc (BNFT):企業の財務・戦略的SWOT分析
    Summary Benefitfocus Inc (Benefitfocus) is a technology service provider that offers cloud- based software solutions. The company provides cloud-based benefits management platform for shopping, enrolling, managing and exchanging benefit information for employers, insurance carriers, brokers, and con …
  • Antitope Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Antitope Ltd (Antitope), a subsidiary of Abzena Plc is a life science company that research and develops technologies for various therapeutic areas. The company’s iTope technology is used to identify peptides; and T cell epitope database is used for screening amino acid sequences from antibo …
  • Danaher Corp (DHR):企業の財務・戦略的SWOT分析
    Danaher Corp (DHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Nice Ltd (NICE):企業の財務・戦略的SWOT分析
    Nice Ltd (NICE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Volkswind GmbH-エネルギー分野:企業M&A・提携分析
    Summary Volkswind GmbH (Volkswind), a subsidiary of Axpo Holding AG, is an independent renewable power producer. It undertakes the planning, development, construction and operations of wind power plants. Volkswind builds wind farms with wind turbines from various suppliers including Seimens, Enercon …
  • Steward Health Care System LLC:企業の戦略的SWOT分析
    Steward Health Care System LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Phytel Inc-製薬・医療分野:企業M&A・提携分析
    Summary Phytel Inc (Phytel), a subsidiary of International Business Machines Corporation is an integrated population health management software and solutions provider. The company’s services include reduce total cost of care, prepare for value based care, increase patient engagement, measure quality …
  • InteRNA Technologies BV-製薬・医療分野:企業M&A・提携分析
    Summary InteRNA Technologies BV (InteRNA) is a biotechnology company that specializes in the development of RNA therapeutics for the treatment of cancer. The company develops technologies in biomedical research translating miRNA sequence fields. Its drug development programs focuses on developing mi …
  • PDS Biotechnology Corp-製薬・医療分野:企業M&A・提携分析
    Summary PDS Biotechnology Corp (PDS Biotechnology) is a biopharmaceutical company that develops immunotherapies and vaccines for cancer and infectious disease. The company uses versamune technology, which is immunostimulatory nanoparticle vaccine platform used for the development of cancer immunothe …
  • Berjaya Corporation Berhad:企業の戦略・SWOT・財務分析
    Berjaya Corporation Berhad - Strategy, SWOT and Corporate Finance Report Summary Berjaya Corporation Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Engepack Embalagens Sa
    Engepack Embalagens Sa - Strategy, SWOT and Corporate Finance Report Summary Engepack Embalagens Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Willis Towers Watson Public Ltd Co:戦略・SWOT・企業財務分析
    Willis Towers Watson Public Ltd Co - Strategy, SWOT and Corporate Finance Report Summary Willis Towers Watson Public Ltd Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Costco Wholesale Corporation (COST):企業の財務・戦略的SWOT分析
    Costco Wholesale Corporation (COST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • SpringWorks Therapeutics LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary SpringWorks Therapeutics LLC (SpringWorks Therapeutics) is a drug development company that develops therapeutic medicines for various diseases. The company’s pipeline products include Nirogacestat, MEK ½ Inhibitor, Senicapoc and FAAH Inhibitor. Its Nirogacestat is a gamma secretase inhibitor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆